Compare Wipro Limited (WIT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Wipro Limited vs State Street SPDR S&P Biotech ETF — how do they compare? Wipro Limited trades at $1.87 (market cap $18.49B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: Wipro Limited pays a 4.68% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Wipro Limited nearer its low. Which is the better fit depends on your goals.
| WIT | XBI | |
|---|---|---|
Market Cap | $18.49B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $3.06 | $164.28 |
52-Week Low | $1.82 | $85.16 |
Enterprise Value | $16.42B | — |
Dividend Yield | 4.68% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
